Cargando…
Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis
Background. This retrospective observational study attempted to examine the prevalence of abnormal blood aluminum levels in dialysis patients, and to explore the association of pathogenic factors, such as demographic, clinical, laboratory as well as the use of phosphate binding drugs, drugs for seco...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997989/ https://www.ncbi.nlm.nih.gov/pubmed/35409569 http://dx.doi.org/10.3390/ijerph19073885 |
_version_ | 1784684835394027520 |
---|---|
author | Chuang, Po-Hsun Tsai, Kai-Fan Wang, I-Kuan Huang, Ya-Ching Huang, Lan-Mei Liu, Shou-Hsuan Weng, Cheng-Hao Huang, Wen-Hung Hsu, Ching-Wei Lee, Wen-Chin Yen, Tzung-Hai |
author_facet | Chuang, Po-Hsun Tsai, Kai-Fan Wang, I-Kuan Huang, Ya-Ching Huang, Lan-Mei Liu, Shou-Hsuan Weng, Cheng-Hao Huang, Wen-Hung Hsu, Ching-Wei Lee, Wen-Chin Yen, Tzung-Hai |
author_sort | Chuang, Po-Hsun |
collection | PubMed |
description | Background. This retrospective observational study attempted to examine the prevalence of abnormal blood aluminum levels in dialysis patients, and to explore the association of pathogenic factors, such as demographic, clinical, laboratory as well as the use of phosphate binding drugs, drugs for secondary hyperparathyroidism and erythropoiesis-stimulating drugs with the blood aluminum levels. Methods. The study included 1175 patients (874 hemodialysis and 301 peritoneal dialysis), recruited from Chang Gung Memorial Hospital in November 2020. Patients were stratified into two groups by their blood aluminum levels, as normal (<2 µg/dL, n = 1150) or abnormal (≥2 µg/dL, n = 25). Results. The patients aged 60.4 ± 13.2 years and were dialyzed for 8.6 ± 8.1 years. The average blood aluminum level was 1.0 ± 0.4 µg/dL. Patients with abnormal blood aluminum levels received more sevelamer than patients with normal blood aluminum level (p = 0.014). Patients with abnormal blood aluminum levels had higher platelet count (p = 0.001), triglyceride (p < 0.001) and total iron binding capacity (p = 0.003) than patients with normal blood aluminum levels. Moreover, the cardiothoracic ratio was higher in patients with abnormal blood aluminum levels than patients with normal blood aluminum levels (p = 0.003). Conclusions. The prevalence of abnormal blood aluminum levels was low at 2.2%. Nevertheless, the linking of cardiothoracic ratio of more than 0.5 as well as elevated blood platelet count and triglyceride level with blood aluminum levels are interesting, and warranted more researches in this area. |
format | Online Article Text |
id | pubmed-8997989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89979892022-04-12 Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis Chuang, Po-Hsun Tsai, Kai-Fan Wang, I-Kuan Huang, Ya-Ching Huang, Lan-Mei Liu, Shou-Hsuan Weng, Cheng-Hao Huang, Wen-Hung Hsu, Ching-Wei Lee, Wen-Chin Yen, Tzung-Hai Int J Environ Res Public Health Article Background. This retrospective observational study attempted to examine the prevalence of abnormal blood aluminum levels in dialysis patients, and to explore the association of pathogenic factors, such as demographic, clinical, laboratory as well as the use of phosphate binding drugs, drugs for secondary hyperparathyroidism and erythropoiesis-stimulating drugs with the blood aluminum levels. Methods. The study included 1175 patients (874 hemodialysis and 301 peritoneal dialysis), recruited from Chang Gung Memorial Hospital in November 2020. Patients were stratified into two groups by their blood aluminum levels, as normal (<2 µg/dL, n = 1150) or abnormal (≥2 µg/dL, n = 25). Results. The patients aged 60.4 ± 13.2 years and were dialyzed for 8.6 ± 8.1 years. The average blood aluminum level was 1.0 ± 0.4 µg/dL. Patients with abnormal blood aluminum levels received more sevelamer than patients with normal blood aluminum level (p = 0.014). Patients with abnormal blood aluminum levels had higher platelet count (p = 0.001), triglyceride (p < 0.001) and total iron binding capacity (p = 0.003) than patients with normal blood aluminum levels. Moreover, the cardiothoracic ratio was higher in patients with abnormal blood aluminum levels than patients with normal blood aluminum levels (p = 0.003). Conclusions. The prevalence of abnormal blood aluminum levels was low at 2.2%. Nevertheless, the linking of cardiothoracic ratio of more than 0.5 as well as elevated blood platelet count and triglyceride level with blood aluminum levels are interesting, and warranted more researches in this area. MDPI 2022-03-24 /pmc/articles/PMC8997989/ /pubmed/35409569 http://dx.doi.org/10.3390/ijerph19073885 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chuang, Po-Hsun Tsai, Kai-Fan Wang, I-Kuan Huang, Ya-Ching Huang, Lan-Mei Liu, Shou-Hsuan Weng, Cheng-Hao Huang, Wen-Hung Hsu, Ching-Wei Lee, Wen-Chin Yen, Tzung-Hai Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title | Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title_full | Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title_fullStr | Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title_full_unstemmed | Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title_short | Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis |
title_sort | blood aluminum levels in patients with hemodialysis and peritoneal dialysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997989/ https://www.ncbi.nlm.nih.gov/pubmed/35409569 http://dx.doi.org/10.3390/ijerph19073885 |
work_keys_str_mv | AT chuangpohsun bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT tsaikaifan bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT wangikuan bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT huangyaching bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT huanglanmei bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT liushouhsuan bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT wengchenghao bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT huangwenhung bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT hsuchingwei bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT leewenchin bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis AT yentzunghai bloodaluminumlevelsinpatientswithhemodialysisandperitonealdialysis |